The agreement grants Novo Nordisk licensing rights to select oral drug-delivery technologies from Vivtex.
Itvisma works by delivering a functional copy of the survival motor neuron 1 (SMN1) gene through a single, fixed-dose intrathecal injection.
Africa Genome Archiving for Response and Insight (AGARI) is a collaborative initiative developed in partnership with the African Society for Laboratory Medicine (ASLM) and African Union Member States.